IN2015DN01767A - - Google Patents
Info
- Publication number
- IN2015DN01767A IN2015DN01767A IN1767DEN2015A IN2015DN01767A IN 2015DN01767 A IN2015DN01767 A IN 2015DN01767A IN 1767DEN2015 A IN1767DEN2015 A IN 1767DEN2015A IN 2015DN01767 A IN2015DN01767 A IN 2015DN01767A
- Authority
- IN
- India
- Prior art keywords
- probnp
- mortality
- transplantation
- subjects
- prediction
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 108020001621 Natriuretic Peptide Proteins 0.000 abstract 1
- 102000004571 Natriuretic peptide Human genes 0.000 abstract 1
- 102100036836 Natriuretic peptides B Human genes 0.000 abstract 1
- 101710187802 Natriuretic peptides B Proteins 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 239000000692 natriuretic peptide Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Health & Medical Sciences (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261691706P | 2012-08-21 | 2012-08-21 | |
| PCT/US2013/056020 WO2014031764A1 (en) | 2012-08-21 | 2013-08-21 | Multimarker risk stratification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01767A true IN2015DN01767A (enExample) | 2015-05-29 |
Family
ID=50148799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1767DEN2015 IN2015DN01767A (enExample) | 2012-08-21 | 2013-08-21 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20140058743A1 (enExample) |
| EP (1) | EP2888687B1 (enExample) |
| JP (3) | JP6450679B2 (enExample) |
| CN (2) | CN104737170A (enExample) |
| AU (3) | AU2013305829A1 (enExample) |
| CA (1) | CA2882303A1 (enExample) |
| HK (2) | HK1208092A1 (enExample) |
| IN (1) | IN2015DN01767A (enExample) |
| MX (2) | MX375520B (enExample) |
| RU (1) | RU2015110054A (enExample) |
| SG (2) | SG10201608854TA (enExample) |
| WO (1) | WO2014031764A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| ES2375181T3 (es) | 2002-05-09 | 2012-02-27 | The Brigham And Women's Hospital, Inc. | 1l 1rl-1 como un marcador de enfermedades cardiovasculares. |
| PL2386860T4 (pl) | 2006-04-24 | 2015-09-30 | Critical Care Diagnostics Inc | Przewidywanie śmiertelności i wykrywanie poważnej choroby |
| DK2482078T3 (en) | 2006-05-01 | 2016-05-02 | Critical Care Diagnostics Inc | Cardiovascular disease diagnosis |
| PT3093663T (pt) | 2008-04-18 | 2018-10-19 | Critical Care Diagnostics Inc | Previsão do risco de eventos cardíacos adversos maiores |
| RU2684724C2 (ru) | 2010-04-09 | 2019-04-11 | Критикал Кэа Дайэгностикс, Инк. | Антитела против растворимого st-2 человека и способы анализа |
| CN103718046B (zh) | 2011-03-17 | 2016-10-12 | 重症监护诊断股份有限公司 | 预测不良临床结果的风险的方法 |
| PL2734222T3 (pl) | 2011-07-18 | 2017-03-31 | Critical Care Diagnostics, Inc. | Sposoby leczenia chorób układu krążenia i prognozowania skuteczności terapii ruchowej |
| AU2013262515B2 (en) | 2012-05-18 | 2018-03-15 | Cardiac Pacemakers, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| MX358541B (es) | 2012-08-16 | 2018-08-24 | Critical Care Diagnostics Inc | Metodos para predecir el riesgo de desarrollar hipertension. |
| IN2015DN01767A (enExample) | 2012-08-21 | 2015-05-29 | Critical Care Diagnostics Inc | |
| US20150199491A1 (en) * | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| CA2996903C (en) | 2015-08-28 | 2024-01-02 | Mcmaster University | Method of determining risk of an adverse cardiac event |
| US20170220749A1 (en) * | 2016-02-01 | 2017-08-03 | MD Aware LLC | Systems and methods for identifying and using medical calculators |
| EP3446124B1 (en) * | 2016-04-18 | 2026-08-05 | Roche Diagnostics GmbH | Soluble st2 for the identification of progressors to lvh in the general population |
| US12014832B2 (en) * | 2017-06-02 | 2024-06-18 | University Of Florida Research Foundation, Incorporated | Method and apparatus for prediction of complications after surgery |
| RU2677611C1 (ru) * | 2018-04-16 | 2019-01-17 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Способ прогнозирования неблагоприятных сердечно-сосудистых событий в течение 12 месяцев у больных хронической сердечной недостаточностью с рецидивом стенокардии после реваскуляризации миокарда |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| EP3969620B1 (en) * | 2019-05-17 | 2025-06-25 | Regeneron Pharmaceuticals, Inc. | Genome-based methods for reducing cardiovascular risk |
| US20220399122A1 (en) * | 2019-11-01 | 2022-12-15 | Nec Corporation | Risk prediction apparatus, risk prediction method, and computer program |
| CN118760892B (zh) * | 2024-09-05 | 2024-11-19 | 温州市中心医院 | 铁死亡评分确定方法、系统及设备 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| US5206140A (en) | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
| JPH0731479Y2 (ja) | 1989-06-02 | 1995-07-19 | 内橋エステック株式会社 | 温度ヒューズ |
| US5217899A (en) | 1990-08-24 | 1993-06-08 | The General Hospital Corporation | Cell stretching apparatus |
| JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体 |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| JP2732005B2 (ja) | 1992-12-14 | 1998-03-25 | 眞一 富永 | ヒトｓｔ２をコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法 |
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| AU7235296A (en) | 1996-08-23 | 1998-03-06 | Human Genome Sciences, Inc. | T1 receptor-like ligand ii |
| CA2282401A1 (en) | 1997-02-28 | 1998-09-03 | Human Genome Sciences, Inc. | T1/st2-receptor ligand iii |
| WO1998043630A1 (en) | 1997-04-02 | 1998-10-08 | Brigham And Women's Hospital, Inc. | Means of ascertaining an individual's risk profile for atherosclerotic disease |
| US6210976B1 (en) | 1997-06-10 | 2001-04-03 | Medlyte Diagnostics, Inc. | Methods for early detection of heart disease |
| AU731858B2 (en) | 1997-09-11 | 2001-04-05 | Shionogi & Co., Ltd. | Immunoassay for BNP |
| US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
| GB9827348D0 (en) | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
| AU2055300A (en) | 1998-12-18 | 2000-07-03 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
| AU5309600A (en) | 1999-06-02 | 2000-12-18 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of immune disorders |
| FR2795823B1 (fr) | 1999-07-01 | 2001-11-23 | Inst Nat Sante Rech Med | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial |
| US6323334B1 (en) | 1999-09-24 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding a 103 gene product and uses therefor |
| WO2001070817A1 (en) | 2000-03-21 | 2001-09-27 | Medical & Biological Laboratories Co., Ltd. | Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same |
| FR2807170B1 (fr) | 2000-03-30 | 2002-06-28 | Sipal | Charniere elastique a frottement reduit |
| RU2002110275A (ru) | 2000-08-22 | 2004-03-27 | Дзе Брихэм Энд Уимен'З Хоспитал, Инк. (Us) | Диагностика и лечение сердечно-сосудистых состояний |
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| US6537221B2 (en) | 2000-12-07 | 2003-03-25 | Koninklijke Philips Electronics, N.V. | Strain rate analysis in ultrasonic diagnostic images |
| FI20010019A7 (fi) | 2001-01-05 | 2002-07-06 | Biohit Oyj | Menetelmä atrofisen gastriitin diagnostisoimiseksi |
| US20040253637A1 (en) | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| EP1322957B1 (en) | 2001-05-04 | 2009-08-12 | Biosite Incorporated | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| WO2003022987A2 (en) | 2001-07-26 | 2003-03-20 | Eos Biotechnology, Inc. | Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection |
| US6810284B1 (en) | 2001-11-21 | 2004-10-26 | Pacesetter, Inc. | Implantable cardiac stimulation system and method for monitoring diastolic function |
| ES2375181T3 (es) | 2002-05-09 | 2012-02-27 | The Brigham And Women's Hospital, Inc. | 1l 1rl-1 como un marcador de enfermedades cardiovasculares. |
| US8263325B2 (en) | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
| AU2003299441A1 (en) | 2002-12-19 | 2004-07-14 | Centre National De La Recherche Scientifique - Cnrs | Nf-hev compositions and methods of use |
| US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
| US20040220155A1 (en) | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
| US20050123451A1 (en) | 2003-10-31 | 2005-06-09 | Hiroshi Nomura | System and apparatus for body fluid analysis using surface-textured optical materials |
| EP1711622A2 (en) | 2003-11-26 | 2006-10-18 | Applera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| AU2004296829A1 (en) | 2003-12-05 | 2005-06-23 | The Cleveland Clinic Foundation | Risk markers for cardiovascular disease |
| US20050196817A1 (en) | 2004-01-20 | 2005-09-08 | Molecular Staging Inc. | Biomarkers for sepsis |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| JP2005291899A (ja) | 2004-03-31 | 2005-10-20 | Akira Matsumori | 心疾患の検査法 |
| CA2595794A1 (en) | 2005-01-24 | 2006-07-27 | F. Hoffmann-La Roche Ag | The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs |
| EP1731910A1 (en) | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| US20070021977A1 (en) | 2005-07-19 | 2007-01-25 | Witt Biomedical Corporation | Automated system for capturing and archiving information to verify medical necessity of performing medical procedure |
| JP4820192B2 (ja) | 2006-03-17 | 2011-11-24 | 一般財団法人化学及血清療法研究所 | 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 |
| PL2386860T4 (pl) | 2006-04-24 | 2015-09-30 | Critical Care Diagnostics Inc | Przewidywanie śmiertelności i wykrywanie poważnej choroby |
| ATE517341T1 (de) | 2006-04-27 | 2011-08-15 | Critical Care Diagnostics Inc | Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen |
| DK2482078T3 (en) | 2006-05-01 | 2016-05-02 | Critical Care Diagnostics Inc | Cardiovascular disease diagnosis |
| SI2019965T1 (sl) | 2006-05-02 | 2015-10-30 | Critical Care Diagnostics, Inc. | Diferencialna diagnoza med pljučno boleznijo in boleznijo srca in ožilja |
| WO2007130627A2 (en) | 2006-05-04 | 2007-11-15 | The Brigham And Women's Hospital, Inc. | Il-33 in the treatment and diagnosis of diseases and disorders |
| RU2312591C1 (ru) | 2006-06-14 | 2007-12-20 | Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" | Способ прогнозирования развития риска внезапной смерти у больных с лево- и правожелудочковой экстрасистолией |
| CA2554659A1 (en) * | 2006-07-25 | 2006-11-24 | 1128971 Alberta Ltd. | Hanger flange for hanging a tubular body in a well |
| WO2008116083A1 (en) * | 2007-03-22 | 2008-09-25 | Cv Therapeutics, Inc. | Use of ranolazine for elevated brain-type natriuretic peptide |
| JP2010526555A (ja) * | 2007-05-11 | 2010-08-05 | タフツ・メディカル・センター | 加齢関連黄斑変性と関係するポリヌクレオチド及び患者のリスクを評価する方法 |
| WO2009040133A1 (en) * | 2007-09-26 | 2009-04-02 | Universitätsklinikum Heidelberg | Osteopontin as novel prognostic biomarker for heart failure |
| FR2923029B1 (fr) | 2007-10-26 | 2009-11-20 | Minima | Lunettes de type sans entourage a branches filaires |
| WO2009075566A1 (en) * | 2007-12-12 | 2009-06-18 | Erasmus University Medical Center Rotterdam | Biomarkers for cardiovascular disease |
| PT3093663T (pt) | 2008-04-18 | 2018-10-19 | Critical Care Diagnostics Inc | Previsão do risco de eventos cardíacos adversos maiores |
| US20100159474A1 (en) * | 2008-11-11 | 2010-06-24 | B.R.A.H.M.S. Aktiengesellschaft | Prognosis and risk assessment in patients suffering from heart failure by determining the level of adm and bnp |
| CA2765516A1 (en) * | 2009-07-01 | 2011-01-06 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for predicting cardiovascular mortality risk |
| EP2568294B1 (en) * | 2009-11-13 | 2015-01-07 | BG Medicine, Inc. | Risk Factors and Prediction of Myocardial Infaraction |
| US8258456B2 (en) * | 2009-11-27 | 2012-09-04 | Himax Imaging, Inc. | Image sensor |
| RU2684724C2 (ru) | 2010-04-09 | 2019-04-11 | Критикал Кэа Дайэгностикс, Инк. | Антитела против растворимого st-2 человека и способы анализа |
| RU2017110678A (ru) * | 2010-11-01 | 2019-01-24 | Б.Р.А.Х.М.С Гмбх | Оценка прогноза и риска пациентов с неспецифическими жалобами |
| RU2452394C1 (ru) | 2010-11-09 | 2012-06-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Ульяновский государственный университет | Способ прогнозирования риска смерти больных хронической сердечной недостаточностью |
| CN103718046B (zh) | 2011-03-17 | 2016-10-12 | 重症监护诊断股份有限公司 | 预测不良临床结果的风险的方法 |
| PL2734222T3 (pl) | 2011-07-18 | 2017-03-31 | Critical Care Diagnostics, Inc. | Sposoby leczenia chorób układu krążenia i prognozowania skuteczności terapii ruchowej |
| AU2013262515B2 (en) | 2012-05-18 | 2018-03-15 | Cardiac Pacemakers, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| MX358541B (es) | 2012-08-16 | 2018-08-24 | Critical Care Diagnostics Inc | Metodos para predecir el riesgo de desarrollar hipertension. |
| IN2015DN01767A (enExample) | 2012-08-21 | 2015-05-29 | Critical Care Diagnostics Inc | |
| JP6178687B2 (ja) | 2013-09-27 | 2017-08-09 | 富士機械工業株式会社 | グラビア塗工装置 |
| US20150199491A1 (en) | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| USD770057S1 (en) | 2014-04-14 | 2016-10-25 | Critical Care Diagnostics, Inc. | Blood test kit |
| US9934249B2 (en) | 2014-06-03 | 2018-04-03 | Conduent Business Machines Services, Llc | Systems and methods for context-aware and personalized access to visualizations of road events |
| USD800332S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
| USD800333S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
| US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
-
2013
- 2013-08-21 IN IN1767DEN2015 patent/IN2015DN01767A/en unknown
- 2013-08-21 MX MX2015002254A patent/MX375520B/es active IP Right Grant
- 2013-08-21 CN CN201380054795.8A patent/CN104737170A/zh active Pending
- 2013-08-21 JP JP2015528625A patent/JP6450679B2/ja not_active Expired - Fee Related
- 2013-08-21 CN CN202010424423.1A patent/CN111834009A/zh active Pending
- 2013-08-21 US US13/972,596 patent/US20140058743A1/en not_active Abandoned
- 2013-08-21 AU AU2013305829A patent/AU2013305829A1/en not_active Abandoned
- 2013-08-21 EP EP13831501.5A patent/EP2888687B1/en active Active
- 2013-08-21 SG SG10201608854TA patent/SG10201608854TA/en unknown
- 2013-08-21 RU RU2015110054A patent/RU2015110054A/ru not_active Application Discontinuation
- 2013-08-21 WO PCT/US2013/056020 patent/WO2014031764A1/en not_active Ceased
- 2013-08-21 HK HK15108723.0A patent/HK1208092A1/xx unknown
- 2013-08-21 HK HK15112621.5A patent/HK1212057A1/xx unknown
- 2013-08-21 SG SG11201501271TA patent/SG11201501271TA/en unknown
- 2013-08-21 CA CA2882303A patent/CA2882303A1/en not_active Abandoned
-
2015
- 2015-02-20 MX MX2020009943A patent/MX2020009943A/es unknown
-
2016
- 2016-12-20 US US15/385,095 patent/US10303844B2/en active Active
-
2018
- 2018-12-10 JP JP2018230514A patent/JP6621520B2/ja not_active Expired - Fee Related
-
2019
- 2019-03-13 AU AU2019201709A patent/AU2019201709B2/en not_active Ceased
- 2019-04-10 US US16/380,513 patent/US10741290B2/en not_active Expired - Fee Related
- 2019-11-19 JP JP2019208375A patent/JP6902083B2/ja not_active Expired - Fee Related
-
2020
- 2020-07-07 US US16/922,580 patent/US20200335220A1/en not_active Abandoned
-
2021
- 2021-04-06 AU AU2021202116A patent/AU2021202116A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP6621520B2 (ja) | 2019-12-18 |
| JP2020034573A (ja) | 2020-03-05 |
| US20200335220A1 (en) | 2020-10-22 |
| JP2015532715A (ja) | 2015-11-12 |
| MX2015002254A (es) | 2015-05-08 |
| JP2019053086A (ja) | 2019-04-04 |
| US10303844B2 (en) | 2019-05-28 |
| CN111834009A (zh) | 2020-10-27 |
| AU2013305829A1 (en) | 2015-03-05 |
| EP2888687A4 (en) | 2016-04-13 |
| US20190237197A1 (en) | 2019-08-01 |
| SG10201608854TA (en) | 2016-12-29 |
| HK1212057A1 (en) | 2016-06-03 |
| JP6450679B2 (ja) | 2019-01-09 |
| EP2888687B1 (en) | 2023-08-02 |
| MX375520B (es) | 2025-03-06 |
| CA2882303A1 (en) | 2014-02-27 |
| US20170169179A1 (en) | 2017-06-15 |
| AU2021202116A1 (en) | 2021-05-06 |
| JP6902083B2 (ja) | 2021-07-14 |
| RU2015110054A (ru) | 2016-10-10 |
| AU2019201709A1 (en) | 2019-04-04 |
| AU2019201709B2 (en) | 2021-01-07 |
| US10741290B2 (en) | 2020-08-11 |
| MX2020009943A (es) | 2020-10-16 |
| CN104737170A (zh) | 2015-06-24 |
| WO2014031764A1 (en) | 2014-02-27 |
| EP2888687A1 (en) | 2015-07-01 |
| HK1208092A1 (en) | 2016-02-19 |
| SG11201501271TA (en) | 2015-03-30 |
| US20140058743A1 (en) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020009943A (es) | Estratificacion de riesgo para marcador multiple. | |
| WO2009129454A3 (en) | Predicting risk of major adverse cardiac events | |
| EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
| EA201690213A1 (ru) | Композиции и способ лечения связанных с комплементом состояний | |
| MX360236B (es) | Uso de marcadores en el diagnostico y tratamiento de cancer de prostata. | |
| PH12014502436A1 (en) | In vitro method for the diagnosis and surveillance of cancer | |
| MX360479B (es) | Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. | |
| WO2011085057A3 (en) | Methods for detecting insulin autoantibody | |
| WO2012122334A3 (en) | Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases | |
| FI20115367A0 (fi) | Menetelmä sydän- ja verisuonitapahtumien määrittämiseksi käyttämällä IGFBP-fragmentteja | |
| WO2013167727A3 (en) | Method for determining arthritis relapse risk | |
| BR112013017683A2 (pt) | método de medir a concentração de um analito em uma solução aquosa | |
| GB201114909D0 (en) | Biomarkers for lysosomal storage disorders | |
| MX384636B (es) | Método para detectar anticuerpos neutralizantes contra la insulina humana recombinante en suero humano. | |
| WO2012122094A3 (en) | Biomarkers of cardiac ischemia | |
| NZ759287A (en) | Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose | |
| EP3339861C0 (en) | BIOMARKERS USED TO PREDICTE OR EARLY DETECT PRE-ECLAMPSIA | |
| EA201391772A1 (ru) | Способ диагностики ревматоидного артрита | |
| TH148990A (th) | การจัดกลุ่มความเสี่ยงของมัลติมาร์คเกอร์ | |
| RU2013105660A (ru) | Способ прогнозирования стадии рассеянного склероза с учетом показателей биохимического статуса | |
| RU2012144141A (ru) | Способ оценки вероятности возникновенения переломов при остеопорозе у женщин | |
| UA81994U (ru) | Способ прогнозирования развития нестабильной стенокардии у больных с сахарным диабетом 2 типа | |
| UA85502U (ru) | Способ оценки прогноза течения хронической болезни почек на фоне хронического пиелонефрита с наличием артериальной гипертензии | |
| UA82989U (uk) | Спосіб прогнозування ризику розвитку артеріальної гіпертензії у хворих на акромегалію | |
| ZHANG | Clinical significance and application of midregional pro-atrial natriuretic peptide |